Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.48
0.356.82%
At close: Jun 5, 5:00 PM EST
$5.52
0.397.60%
Pre-Market: 7:35 AM EST
Achieve Life Sciences Inc Analyst Ratings
ACHVNASDAQ
Achieve Life Sciences Analyst Ratings and Price Targets | NASDAQ:ACHV | Benzinga
Achieve Life Sciences Inc has a consensus price target of $14.75 based on the ratings of 8 analysts. The high is $20 issued by Raymond James on September 27, 2024. The low is $11 issued by Oppenheimer on August 15, 2024. The 3 most-recent analyst ratings were released by Canaccord Genuity, HC Wainwright & Co., and HC Wainwright & Co. on April 21, 2026, April 16, 2026, and March 25, 2026, respectively. With an average price target of $12.33 between Canaccord Genuity, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 123.43% upside for Achieve Life Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
HC Wainwright & Co.
Citizens
Rodman & Renshaw
Raymond James
1calculated from analyst ratings
Analyst Ratings for Achieve Life Sciences
Loading calendar...
FAQ
What is the target price for Achieve Life Sciences (ACHV) stock?
The latest price target for Achieve Life Sciences (NASDAQ:ACHV) was reported by Canaccord Genuity on April 21, 2026. The analyst firm set a price target for $13.00 expecting ACHV to rise to within 12 months (a possible 135.51% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Achieve Life Sciences (ACHV)?
The latest analyst rating for Achieve Life Sciences (NASDAQ:ACHV) was provided by Canaccord Genuity, and Achieve Life Sciences initiated their buy rating.
When was the last upgrade for Achieve Life Sciences (ACHV)?
There is no last upgrade for Achieve Life Sciences
When was the last downgrade for Achieve Life Sciences (ACHV)?
There is no last downgrade for Achieve Life Sciences.
When is the next analyst rating going to be posted or updated for Achieve Life Sciences (ACHV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Achieve Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Achieve Life Sciences was filed on April 21, 2026 so you should expect the next rating to be made available sometime around April 21, 2027.
Is the Analyst Rating Achieve Life Sciences (ACHV) correct?
While ratings are subjective and will change, the latest Achieve Life Sciences (ACHV) rating was a initiated with a price target of $0.00 to $13.00. The current price Achieve Life Sciences (ACHV) is trading at is $5.52, which is within the analyst’s predicted range.
